TP53 and cancer: They then used the same method to achieve simultaneous silencing of pten and p53 genes in liver cells and successfully induced liver tumors that mimicked those caused by Cre-loxP mediated deletion of Pten and p53 in 3 months, supporting the use of multiplexed CRISPR editing of cancer genes in liver [43].